Donovan Quill

Boron, LePore & Associates, Inc. provides integrated medical education to the healthcare industry. It provides strategic consultation, content development, accredited & non-accredited program development, logistics management and other internet-based solutions. The company was founded in 1981 and is headquartered in Wayne, NJ.

Manchester Pharmaceuticals is a specialty pharmaceutical company focused on the identification, development, FDA approval and commercialization of new therapeutic modalities to address the special needs of patients with ultra-rare diseases. Manchester markets Chenodal (chenodiol tablets) and Vecamyl (mecamylamine tablets). Manchester’s founders and management have extensive combined experience in the rare disease market.

Hesperian Biopharma LLC is an American company that develops, manufactures, and commercializes novel drug antidotes. Kenneth R. Greathouse has been the CEO of the private company since 2015.

AscellaHealth LLC is a healthcare and specialty pharmacy solutions organization that offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. The private company is based in Berwyn, PA. The company's patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients. AscellaHealth has received numerous industry awards for innovation, including Deloitte Technology Fast 500™ and Inc. 5000. The CEO of the company is Dea Belazi.

Valcrest Pharmaceuticals LLC is a private company that manufactures and supplies pharmaceutical products. The company is based in Tarrytown, NY. The company was founded by Kenneth R. Greathouse and he has been the CEO since incorporation.